InVisionSeq

InVisionSeq™ is a qualitative laboratory developed test that uses targeted advanced sequencing technology to detect single nucleotide variants (SNVs), copy number variants (CNVs), insertions and deletions (InDels) in selected genes from DNA isolated from plasma samples from patients. InVisionSeq™ is available world-wide for both commercial and research use for a range of cancer types. This test is not reimbursed in the US.